Availability and use of fetal fibronectin testing and transvaginal ultrasound for preterm labor evaluation in the United States

Measure availability and use of fetal fibronectin (fFN) testing and transvaginal ultrasound to measure cervical length (TVCL) for symptomatic preterm labor (PTL) patients. Additionally, assess the presence and impact of PTL triage protocols. Cross-sectional online survey among clinicians from 255 un...

Full description

Saved in:
Bibliographic Details
Published in:The journal of maternal-fetal & neonatal medicine 2022-12, Vol.35 (25), p.8586-8593
Main Authors: Ruma, Michael S., Banker, Wendy M.
Format: Article
Language:English
Subjects:
Fetal fibronectin testing (fFN)
guidelines
preterm labor (PTL)
spontaneous preterm birth (sPTB)
transvaginal ultrasound to measure cervical length (TVCL)
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Measure availability and use of fetal fibronectin (fFN) testing and transvaginal ultrasound to measure cervical length (TVCL) for symptomatic preterm labor (PTL) patients. Additionally, assess the presence and impact of PTL triage protocols. Cross-sectional online survey among clinicians from 255 unique hospitals regarding prior 12-month practices (pre-COVID-19). fFN testing was always available in 87% (221) of hospitals, while TVCL was always available in 69% (175) of hospitals. Utilization was lower: fFN specimens were often/always collected in 61% (156) of hospitals and TVCL was often/always performed in 43% (110) of hospitals. fFN testing was significantly more likely than TVCL to be available and used (p 
ISSN:1476-7058
1476-4954
DOI:10.1080/14767058.2021.1989403